Brian Goff
Chief Executive Officer at Agios Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Agios Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Agios Pharmaceuticals Inc. June 18, 202699.3%
-
Intellia Therapeutics Inc. June 9, 202678.6%
-
Agios Pharmaceuticals Inc. June 13, 202396.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | Intellia Therapeutics Inc. | Grant or award | +9,200 | — | — |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +25,528 | — | — |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −12,472 | $34.71 | $432,903 |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +13,500 | — | — |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −6,596 | $34.71 | $228,947 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +8,500 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −3,870 | $28.96 | $112,075 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +18,000 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −8,267 | $28.96 | $239,412 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +13,000 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −5,918 | $28.96 | $171,385 |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +25,528 | — | — |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Open-market sale | −12,473 | $27.09 | $337,894 |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +12,750 | — | — |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Open-market sale | −6,230 | $27.09 | $168,771 |
Questions about Brian Goff
What boards is Brian Goff on?
Brian Goff sits on the boards of Agios Pharmaceuticals Inc. and Intellia Therapeutics Inc.
What company is Brian Goff the CEO of?
Brian Goff is Chief Executive Officer of Agios Pharmaceuticals Inc.
How long has Brian Goff served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.